#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16552	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2618	776.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1590	1590	C	1100	C,G	1099,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28354	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4029	878.0	0	.	n	.	0	T695C	SNP	695	695	T	1249	1249	C	1048	C,T,G	1045,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28354	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4029	878.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1891	1891	A	1189	A	1189	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28354	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4029	878.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2525	2525	C	960	C,T,A,G	956,1,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28354	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4029	878.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2599	2599	A	952	A	952	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28354	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4029	878.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3151	3151	C	974	C,A	973,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2336	folP	852	852	100.0	folP.l15.c4.ctg.1	1991	146.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1250	1252	AGC	237;238;238	A;G;C	237;238;238	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5306	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3799	174.2	1	SNP	p	S91F	0	.	.	271	273	TCC	766	768	TCC	202;200;201	T;C,T;C,T	202;199,1;200,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5306	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3799	174.2	1	SNP	p	D95N	0	.	.	283	285	GAC	778	780	GAC	212;213;213	G,C,A;A,C;C,T	209,1,1;211,1;211,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5306	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3799	174.2	1	SNP	p	D95G	0	.	.	283	285	GAC	778	780	GAC	212;213;213	G,C,A;A,C;C,T	209,1,1;211,1;211,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2204	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1883	146.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	754	756	ACC	222;223;223	A;C;C	222;223;223	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2204	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1883	146.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	769	771	CAC	215;215;217	C;A;C	215;215;217	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2204	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1883	146.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	952	954	CAC	290;290;290	C,T;A;C,G	289,1;290;289,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2204	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1883	146.2	1	SNP	p	G45D	0	.	.	133	135	GGC	772	774	GGC	218;219;219	G,A;G;C,A	217,1;219;218,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1234	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1589	96.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3355	210.2	1	SNP	p	D86N	0	.	.	256	258	GAC	837	839	GAC	227;226;229	G;A,T,G;C	227;224,1,1;229	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3355	210.2	1	SNP	p	S87R	0	.	.	259	261	AGT	840	842	AGT	231;236;239	A;G;T,G	231;236;238,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3355	210.2	1	SNP	p	S87I	0	.	.	259	261	AGT	840	842	AGT	231;236;239	A;G;T,G	231;236;238,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3355	210.2	1	SNP	p	S87W	0	.	.	259	261	AGT	840	842	AGT	231;236;239	A;G;T,G	231;236;238,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3355	210.2	1	SNP	p	S88P	0	.	.	262	264	TCC	843	845	TCC	238;240;239	T;C,A;C	238;239,1;239	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4660	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3157	183.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1882	1884	GGC	265;267;265	G;G;C	265;267;265	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1543	1545	GCA	265;267;268	G;C;A,T	265;267;267,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1546	1548	ATC	266;266;265	A;T,G;C	266;265,1;265	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1558	1560	GTG	265;267;268	G;T;G,C	264;267;267,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1558	1560	GTG	265;267;268	G;T;G,C	264;267;267,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2062	2064	ACC	243;244;249	A,G;C;C	242,1;244;249	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2116	2118	GCG	256;258;258	G;C;G	256;258;258	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2116	2118	GCG	256;258;258	G;C;G	256;258;258	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2239	2241	GGC	229;227;228	G;G;C	228;226;227	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2248	2250	GGC	229;229;227	G;G;C	228;228;226	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4390	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2938	186.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2266	2268	CCG	231;236;238	C,T,G;C;G	228,1,1;235;237	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6246	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3543	219.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2602	porA	1146	1146	99.83	porA.l6.c30.ctg.1	2386	136.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	882	882	C	214	C	213	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	684	686	GTT	280;281;281	G;T;T,G,C	280;281;279,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	0	.	p	.	0	I75V	NONSYN	223	225	ATT	774	776	GTT	286;287;288	G;T;T	286;287;288	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	0	.	p	.	0	S89T	NONSYN	265	267	AGC	816	818	ACC	277;274;274	A;C,T;C,G	277;273,1;273,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	0	.	p	.	0	I98V	NONSYN	292	294	ATC	843	845	GTC	272;273;271	G;T;C	272;273;271	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	1	SNP	p	G120K	1	.	.	358	360	AAG	909	911	AAG	270;271;270	A;A;G	270;271;270	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	1	SNP	p	N121D	0	.	.	361	363	AAC	912	914	AAC	270;271;270	A;A,T;C,A	270;270,1;269,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3278	porB1b	1038	1038	99.52	porB1b.l6.c17.ctg.1	2097	195.0	1	SNP	p	A121N	1	.	.	361	363	AAC	912	914	AAC	270;271;270	A;A,T;C,A	270;270,1;269,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11222	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5356	261.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2261	2263	AAT	330;328;325	A;A;TAAA,TAA	330;328;313,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1682	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1569	133.8	1	SNP	p	V57M	1	.	.	169	171	ATG	831	833	ATG	308;312;312	A;T,G;G,T,C	308;310,2;310,1,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
